ACRV - Acrivon Therapeutics, Inc. Common Stock logo

Acrivon Therapeutics, Inc. Common Stock

ACRV
Net income grew 100% of years1Y
Compare ACRV Hold
โš•๏ธ Healthcare NASDAQ Listed 2022 $ USD
$1,000 invested 1 year ago โ†’$509today

Score Overview

1 Year
Scoreโ€”
Net Growth+5.16%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendShrank
Revenue Consistencyโ€”
All Time
Scoreโ€”
Net Growth-148.97%
Net Trend50%
Net Income Consistency
Rev Growthโ€”
Rev TrendNever
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Acrivon Therapeutics, Inc. Common Stock has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. ACRV does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-11-20
$ 1.15โ€”
1 Year2025-11-20
$ 2.26-49.12%
All Time2022-11-15
$ 16.64-93.09%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

  • Revenue
  • Net Income
  • Cash
Year
TTM$ 0.00-$ 73M$ 77M
2025$ 0.00-$ 77M$ 118M
2024$ 0.00-$ 80M$ 179M
2023$ 0.00-$ 60M$ 127M
IPO2022$ 0.00-$ 29M$ 127M
ACRV - Acrivon Therapeutics, Inc. Common Stock logo

Acrivon Therapeutics, Inc. Common Stock fundamental performance

Across Acrivon Therapeutics, Inc. Common Stock's full reported history, from 2022 to 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 29M to -$ 77M. Revenue increased in 0% of the years measured; net income in 50%.

Membership

Explore ACRV with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,184 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$149 / year

or $19/month

Continue with Membership

30-day money-back guarantee.

Explore other companies